Healthcare -
Biotechnology - NASDAQ - US
$ 1.605
-6.14 %
$ 14.8 M
Market Cap
-0.25
P/E
SABS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SABS - SAB Biotherapeutics, Inc.
66.8 M
LAST VALUE
39.89%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR